| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d7e2f8fb5650d7d3616661464b67771 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-06 |
| filingDate |
2020-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f20a179f7a9a253cb66791598a02a7c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ea7a5f43b7e38ca30d12884577287fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_676d87cce2e5ff5cbb836426da387276
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3949cee19334bd57736bbb66bb3909ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff2f377c6be5410d5e0a652b35532cc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a35fe0031c2e37070b169a6ea524784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a77a51567eb3c02b665bc1fa7312479c |
| publicationDate |
2022-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022144850-A1 |
| titleOfInvention |
Indolo heptamyl oxime analogue as parp inhibitor |
| abstract |
Disclosed is a type of indolo heptamyl oxime compounds as a PARP inhibitor. Specifically disclosed are a compound as represented by formula (II) and a pharmaceutically acceptable salt thereof. |
| priorityDate |
2019-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |